Sartorius Liabilities 2025

Sartorius Aktienanalyse

What does Sartorius do?

Sartorius AG is a globally operating company specializing in the development and manufacturing of laboratory equipment and process technologies. It was founded in 1870 by industrialist and entrepreneur Florenz Sartorius in Göttingen, Germany. The company initially focused on the sale of scales, weights, and measuring instruments but has since expanded and diversified its product line. Today, Sartorius AG is a world leader in the bioprocessing and laboratory equipment sectors and is known for its innovative products and procedures. The company's business model revolves around the development of high-tech products for applications in biotechnology, pharmaceuticals, and the food industry. It operates in two main business segments: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions segment provides solutions and services for biopharmaceutical production, including filtration, fermentation, fluid management, and cell cultures. The products in this segment are typically disposable consumables used in the production of biopharmaceutical agents. The Lab Products & Services segment offers a wide range of laboratory equipment, from scales and microbiology equipment to ultrafiltration devices. These instruments are used by researchers and scientists in academic, industrial, and pharmaceutical laboratories worldwide. Furthermore, an important part of Sartorius' portfolio includes bioreactors and fermenters. These specialized devices are used for cultivating cells and microorganisms and are particularly important in biotechnology and vaccine production. Sartorius has established itself as a leader in this field through its innovative and high-performance products. In addition to the pharmaceutical, biotechnology, and laboratory sectors, Sartorius is also active in environmental technology. The company provides products and services for water analysis and purification, which are in demand in industries such as pharmaceuticals, food production, and environmental analysis due to their precise and reliable results. Sartorius demonstrates its innovation through the use of technologies such as machine learning and artificial intelligence. For example, the company offers the "Ambr" solution for fast and reliable modeling of production scenarios for biopharmaceutical agents. Machine learning techniques are employed to generate more data and make better decisions. Overall, Sartorius AG is a global company with a wide range of products and services for the biotechnology, pharmaceutical, chemical, and food industries. The company's innovation is evident in its continuous advancement of procedures, technologies, and products. With a strong market position and clear strategic direction, Sartorius will continue to be an important player in the industry and support the work of researchers and scientists worldwide with its high-performance products. Sartorius ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Sartorius's Liabilities

Sartorius's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sartorius's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Sartorius's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Sartorius's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Sartorius’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Sartorius stock

What is the level of liabilities of Sartorius this year?

Sartorius has a debt balance of 7.68 B EUR this year.

What were the liabilities of Sartorius compared to the previous year?

The liabilities of Sartorius have increased by 53.93% increased compared to the previous year.

What are the consequences of high debt for investors of Sartorius?

High liabilities can pose a risk for investors of Sartorius, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Sartorius?

Low liabilities mean that Sartorius has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Sartorius affect the company?

An increase in liabilities of Sartorius can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Sartorius affect the company?

A decrease in the liabilities of Sartorius can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Sartorius?

Some factors that can influence the liabilities of Sartorius include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Sartorius so important for investors?

The liabilities of Sartorius are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Sartorius take to modify the liabilities?

To change its liabilities, Sartorius can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Sartorius pay?

Over the past 12 months, Sartorius paid a dividend of 1.43 EUR . This corresponds to a dividend yield of about 0.75 %. For the coming 12 months, Sartorius is expected to pay a dividend of 1.85 EUR.

What is the dividend yield of Sartorius?

The current dividend yield of Sartorius is 0.75 %.

When does Sartorius pay dividends?

Sartorius pays a quarterly dividend. This is distributed in the months of April, April, May, April.

How secure is the dividend of Sartorius?

Sartorius paid dividends every year for the past 27 years.

What is the dividend of Sartorius?

For the upcoming 12 months, dividends amounting to 1.85 EUR are expected. This corresponds to a dividend yield of 0.97 %.

In which sector is Sartorius located?

Sartorius is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sartorius kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sartorius from 4/1/2025 amounting to 0.73 EUR, you needed to have the stock in your portfolio before the ex-date on 3/28/2025.

When did Sartorius pay the last dividend?

The last dividend was paid out on 4/1/2025.

What was the dividend of Sartorius in the year 2024?

In the year 2024, Sartorius distributed 1.43 EUR as dividends.

In which currency does Sartorius pay out the dividend?

The dividends of Sartorius are distributed in EUR.